Supplements that support serotonin production, emotional balance, and overall psychological wellbeing.
33 itemsLow ferritin with normal hemoglobin can still cause fatigue and brain fog. Learn why ferritin is a better early marker than hemoglobin, who’s at risk, how food pairing affects absorption, and why testing matters—without dosage advice.
A focused, evidence-based look at how chronic psychological stress relates to telomere length, what interventions may help, and what telomere testing can and cannot tell you.
Do GABA supplements cross the blood–brain barrier? A focused, evidence-based look at the BBB debate, PharmaGABA vs synthetic, and complementary GABAergic strategies for natural calm.
Do fermented foods act like proto‑psychobiotics? A focused, evidence‑based review of kimchi, kefir, miso, the vagus nerve, and Lactobacillus/Bifidobacterium research for mood and anxiety.
Structural MRI studies suggest mindfulness meditation may increase hippocampal gray matter and support stress regulation—here’s what the evidence shows.
Burnout often shows HPA axis dysregulation with flattened cortisol rhythms—not “adrenal fatigue.” Learn what cortisol patterns reveal and what research says about ashwagandha and rhodiola.
Low ferritin with normal hemoglobin is common and may drive fatigue, brain fog, and restless legs. Learn why ferritin matters, who should test, and safety tips.
A focused, evidence-based look at Bifidobacterium longum 1714 (and NCC3001) as psychobiotics for stress and anxiety, how they may work via the gut–brain axis, and how traditional fermented foods fit in.
What MRI and DTI studies suggest about meditation and brain structure, from cortical thickness and hippocampal volume to amygdala changes, plus outcomes and caveats.
Burnout often alters cortisol’s daily rhythm through HPA-axis dysregulation—not “adrenal fatigue.” Learn what research shows and how adaptogens like ashwagandha and rhodiola may fit.
A focused look at how chronic stress relates to telomere length, what mechanisms and trials suggest, and why telomere testing is not a stress gauge.
A focused, evidence-based look at how supplements may influence deep sleep (N3) and REM, and how they compare with CBT-I for lasting sleep improvements.
Do GABA supplements cross the blood–brain barrier? Explore the science behind oral GABA, PharmaGABA vs synthetic, natural GABA-supportive strategies, and how benzodiazepines act on GABA receptors—plus TCM and Ayurvedic herbs with GABAergic activity.
A focused look at fermented foods as proto‑psychobiotics. Evidence on Lactobacillus/Bifidobacterium strains, the vagus nerve, and traditional ferments like kimchi, kefir, and miso—and what this may mean for mood.
MTHFR C677T is common and usually benign. Learn what it means for folate, homocysteine, and real-world health, plus practical, food-first steps grounded in evidence.
A focused, evidence-based look at how stress and mindfulness practices relate to telomere biology, what testing can (and can’t) tell you, and why oversimplified telomere claims fall short.
Can supplements really increase deep sleep? Explore what research says about magnesium, glycine, melatonin, tart cherry, and traditional botanicals vs. CBT‑I for slow‑wave sleep.
Is fermented PharmaGABA really better than synthetic GABA for calm? Explore the BBB debate, human trial evidence, and how source may—or may not—matter for stress relief.
A focused look at how psychobiotics may influence anxiety via the vagus nerve, highlighting strain-specific human evidence and the role of fermented foods as proto‑psychobiotics.
A focused look at how meditation relates to cortical thickness on MRI — where changes appear, what meta-analyses show, and how practice style and dose may matter.
A focused evidence brief on ashwagandha, cortisol, and burnout—what research suggests about HPA axis dysregulation and how traditional and modern views align.
A focused, evidence-based look at glycine’s potential to support deep (slow-wave) sleep and overall sleep architecture, with a brief comparison to CBT-I and other supplements.
Does oral GABA cross the blood–brain barrier? This focused review weighs human trials, BBB science, PharmaGABA vs synthetic, and GABA-supportive alternatives for natural calm.
Is burnout really “adrenal fatigue”? Evidence suggests burnout reflects HPA axis dysregulation and altered cortisol rhythms—not failing adrenal glands. Learn what studies show and where adaptogens like ashwagandha and rhodiola may fit, plus Ayurvedic/TCM perspectives.
Anxiety and stress exist on a continuum from adaptive, short-term arousal to persistent, impairing conditions such as generalized anxiety disorder (GAD) and panic disorder. Western biomedicine defines specific syndromes using standardized criteria and emphasizes evidence-based psychotherapy and pharmacotherapy. Eastern and traditional systems view anxiety as dysregulated mind–body energy or imbalance across organ systems, prioritizing practices that train attention, calm the autonomic nervous system, and restore resilience—often through meditation, breath, movement, and botanicals. A growing integrative model blends these strengths: pairing the robust symptom relief of cognitive behavioral therapy (CBT) and selective serotonin reuptake inhibitors (SSRIs)/serotonin–norepinephrine reuptake inhibitors (SNRIs) with mindfulness, yoga, and targeted herbal supports for stress physiology and sleep. In Western care, diagnosis relies on DSM-5-TR criteria. GAD features excessive, hard-to-control worry for at least six months with symptoms like restlessness, fatigue, muscle tension, irritability, poor concentration, and sleep disturbance. Panic disorder involves recurrent, unexpected panic attacks and persistent concern or behavioral change related to attacks. Clinicians exclude medical causes (e.g., hyperthyroidism, arrhythmias), substance effects, and assess functional impairment and comorbidity (depression, PTSD, substance use). First-line treatments with the strongest evidence are CBT (including exposure-based techniques) and SSRIs/SNRIs. CBT teaches skills to modify catastrophic thinking, increase tolerance of physical sensations, and reduce avoidance—producing large, durable effects across anxiety disorders. SSRIs/SNRIs reduce core symptoms but require weeks to full effect and can cause side effects (e.g., GI upset, sexual dysfunction). Benzodiazepines can relieve acute anxiety but carry dependence, cognitive, and accident risks, so guidelines reserve them for short-term
Depression (Major Depressive Disorder, MDD) is a common, potentially severe mood disorder marked by persistent low mood and/or loss of interest or pleasure, along with changes in sleep, appetite, energy, concentration, and thoughts of worthlessness or suicide. In Western medicine, MDD is diagnosed using DSM-5 criteria: at least five of nine symptoms present for two weeks or more, causing distress or impairment, with one being depressed mood or anhedonia, and not better explained by substances, a medical condition, or bipolar disorder. Severity ranges from mild to severe and may include specifiers (e.g., melancholic, peripartum, seasonal). Effective care is guided by symptom severity, patient preference, medical comorbidities, and past treatment response. Western approaches are highly evidence-based. Psychotherapies such as cognitive behavioral therapy (CBT), behavioral activation (BA), and interpersonal therapy (IPT) have strong support, particularly for mild to moderate depression; BA can be as effective as CBT and is often more scalable. First-line medications include selective serotonin reuptake inhibitors (SSRIs) like sertraline and escitalopram due to favorable tolerability; serotonin–norepinephrine reuptake inhibitors (SNRIs) are also common. Alternatives such as bupropion or mirtazapine can be chosen based on symptom profile (e.g., low energy or insomnia). In treatment-resistant depression (often defined after at least two adequate medication trials), evidence-based options include augmentation strategies (e.g., lithium or certain atypical antipsychotics), electroconvulsive therapy (ECT), repetitive transcranial magnetic stimulation (rTMS), and ketamine/esketamine. A stepped-care model is widely endorsed: start with low-intensity interventions for mild cases, step up to combined psychotherapy and pharmacotherapy as needed, and use somatic treatments for resistant or severe illness—always with ongoing symptom monitoring (e.g., PHQ-9) and safety checks. In “e
Attention-deficit/hyperactivity disorder (ADHD) and anxiety disorders frequently co-occur across the lifespan. In children and adolescents with ADHD, about one-quarter to one-third have a current a...
Chronic pain and depression frequently travel together, creating a bidirectional cycle where each condition can precipitate, amplify, and maintain the other. Epidemiologic studies show substantiall...
Depression and anxiety frequently travel together, share many risk factors, and respond to overlapping treatments. Epidemiologic studies show high bidirectional comorbidity: a large proportion of p...
Hypothyroidism and depression frequently overlap clinically and biologically. Thyroid hormones influence brain development, neurotransmission, and energy metabolism; when thyroid levels are low (ov...
IBS and anxiety frequently travel together through a shared gut–brain axis. IBS is a disorder of gut–brain interaction defined by recurrent abdominal pain with altered bowel habits, while anxiety e...
Migraines and depression frequently co-occur and influence one another in clinically meaningful ways. Population studies consistently show a bidirectional association: people with migraine have abo...
Parkinson’s disease (PD) and depression frequently co-occur and influence each other’s course, symptoms, and treatment choices. Depression is among the most common non-motor symptoms of PD, affecti...
